Created by potrace 1.16, written by Peter Selinger 2001-2019

beatandraise

beta

Latest Financials

Filings:

By CategoryBy DateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

Company Exhibits:

IndenturesMaterial Contracts & Credit AgreementsPlans of ReorganizationArticles and BylawsUnderwriting Agreements

SEC Edgar

MYRIAD GENETICS INC

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019

beatandraise.com

beta

Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

MYRIAD GENETICS INC

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
Created by potrace 1.16, written by Peter Selinger 2001-2019

beatandraise.com

beta

Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

MYRIAD GENETICS INC

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
$MYGN

MYRIAD GENETICS INC

CIK:0000899923|SEC Filings

INDENTURES

EX-4.3
formofindentures-3exhibit.htm
Feb 24, 2026
EX-4.3
maximum-formofindenturesx3.htm
Nov 8, 2023
EX-4.2
mygn-20201231xexx42.htm
Mar 16, 2021
EX-4.1
dex41.htm
Aug 15, 2011
EX-4.2
a2090057zex-4_2.htm
Sep 27, 2002
EX-4.4
a2090057zex-4_4.htm
Sep 27, 2002
EX-4.1
dex41.txt
Nov 9, 2001
EX-4.2
dex42.txt
Nov 9, 2001
EX-4.2
dex42.txt
Sep 28, 2001
EX-4.1
dex41.txt
Jul 18, 2001
EX-4.1
dex41.txt
Jul 18, 2001
EX-4.4
0002.txt
Nov 22, 2000
EX-4.5
0003.txt
Nov 22, 2000